The Company started out writing application & consulting before stepping in to acquire these assets, which is ongoing. Though MariMed is a Tier III MSO, it has margins and a cash position that stands out vs. peers. The podcast covers listing on the CSE, recent performance, markets of interest, product roadmap, and more.